SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model

Autor: Suling Liu, Max S. Wicha, Nader Tawakkol, Fayaz Malik, Trenton L. Baker, Amanda K. Paulson, Celina G. Kleer, Ahmed A. Quraishi, Aleix Prat, Hasan Korkaya, Gwangil Kim, Elif Serap Esen, Dafydd G. Thomas, Sumeyye Korkaya, Shawn G. Clouthier, Maria Ouzounova, Rosemarie C. D'Angelo, April Davis
Přispěvatelé: University of Michigan [Ann Arbor], University of Michigan System
Rok vydání: 2014
Předmět:
Cancer Research
Carcinogenesis
[SDV]Life Sciences [q-bio]
Suppressor of Cytokine Signaling Proteins
Triple Negative Breast Neoplasms
medicine.disease_cause
Molecular oncology
Article
Metastasis
Mice
03 medical and health sciences
0302 clinical medicine
Circulating tumor cell
Cancer stem cell
Genetics
medicine
Animals
Humans
PTEN
skin and connective tissue diseases
Molecular Biology
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
Inflammation
0303 health sciences
biology
Interleukin-6
PTEN Phosphohydrolase
medicine.disease
Receptors
Interleukin-6

Xenograft Model Antitumor Assays
3. Good health
Gene Expression Regulation
Neoplastic

Carcinoma
Intraductal
Noninfiltrating

Suppressor of Cytokine Signaling 3 Protein
030220 oncology & carcinogenesis
Cancer research
biology.protein
Female
Tumor Suppressor Protein p53
Stem cell
Zdroj: Oncogene
Oncogene, Nature Publishing Group, 2015, 34 (6), pp.671-680. ⟨10.1038/onc.2014.4⟩
ISSN: 1476-5594
0950-9232
DOI: 10.1038/onc.2014.4
Popis: Somatic mutations or deletions of TP53 and PTEN in ductal carcinoma in situ lesions have been implicated in progression to invasive ductal carcinomas. A recent molecular and mutational analysis of breast cancers revealed that inactivation of tumor suppressors, p53 and PTEN, are strongly associated with triple negative breast cancer. In addition, these tumor suppressors have important roles in regulating self-renewal in normal and malignant stem cells. To investigate their role in breast carcinogenesis, we knocked down these genes in human mammary cells and in non-transformed MCF10A cells. p53 and PTEN knockdown synergized to activate pro-inflammatory interleukin-6 (IL6)/Stat3/nuclear factor κB signaling. This resulted in generation of highly metastatic epithelial-to-mesenchymal transition-like cancer stem cells resulting in tumors whose gene expression profile mimicked that found in basal/claudin-low molecular subtype within the triple negative breast tumors. Constitutive activation of this loop in transformed cells was dependent on proteolytic degradation of suppressor of cytokine signaling 3 (SOCS3) resulting in low levels of this protein in basal/claudin-low cell lines and primary tumors. In non-transformed cells, transient activation of the IL6 inflammatory loop induced SOCS3 expression leading to pathway inactivation. In transformed cells, enforced expression of SOCS3 or interfering with IL6 pathway via IL6R blockade inhibited tumor growth and metastasis in mouse xenograft models. Furthermore, circulating tumor cells were significantly reduced in tumor-bearing animals when treated with anti-IL6R antibodies. These studies uncover important connections between inflammation and carcinogenesis and suggest that blocking pro-inflammatory cytokines may be utilized as an attractive strategy to target triple negative breast tumors, which currently lacks molecularly targeted therapies.
Databáze: OpenAIRE